Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:42 PM
Ignite Modification Date:
2025-12-24 @ 10:42 PM
NCT ID:
NCT02053935
Eligibility Criteria:
Inclusion Criteria:
1. Healthy subjects
2. Age 18-35 years
3. Hemoglobin \>12 g/dl
4. Euthyroid or on a stable dose of synthroid
5. Normal EKG, hemoglobin AIC, kidney and liver function
Exclusion Criteria:
1. Prior history of dopamine infusion
2. Past medical history of diabetes, hypertension, myocardial infarction, vaso-occlusive disease or arrhythmias
3. Chronic steroid therapy, oral contraceptive pills, monoamine oxidase inhibitors (MAO-I), anticonvulsants (phenytoin)
4. Pregnant women because dopamine is pregnancy category C
5. Clinical signs of polycystic ovarian syndrome
6. Past medical history of Cushing's disease or pheochromocytoma
7. Sulfa drug allergy
8. Use of any medications or illness determined by the investigators that may affect insulin secretion or insulin sensitivity.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
35 Years
Study:
NCT02053935
Study Brief:
Protocol Section:
NCT02053935